Vezocolmitide

N/A

Report date: 2024/01/02 11:51:42
NME

Base Information

Drug NameVezocolmitide
Drug Alias NameST-100
ClassificationSmall molecules > Synthetic peptide
Mechanisms of ActionCollagenase replacements
TargetsCollagen
Therapy Area/IndicationsDry Eye Syndromes
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaN/A
Originator CompaniesStuart Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesOra IncStuart Therapeutics IncAju Pharm Co Ltd
Inactive CompaniesN/A
Active IndicationsDry Eye Syndromes
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A